Respiratory Syncytial Virus, or RSV, is a viral infection in the respiratory tract that causes cold-like symptoms. While it is common in children, and typically resolves after a week or two, it can lead to more serious conditions, most notably Bronchiolitis.

Symptoms of RSV typically include:
  • Runny Nose
  • Decrease in Appetite
  • Coughing
  • Sneezing
  • Fever
  • Wheezing

Bronchiolitus

Bronchiolitis is a condition causing the small airways of the lungs (Bronchioles) to become inflames, and congested. While this may begin with symptoms similiar to a cold, it can progress to persistent coughing, wheezing, and difficulty breathing, and may even require hospitalization.

Why treat RSV with BCV?

Continuous Negative Extra-Thoracic Pressure

By means of the negative pressure generated within the shell, the chest wall is held open, creating pathways for mucus to exit the lungs and recruitment of the alveoli to promote better gas exchange.

Control Mode

Biphasic ventilation utilizes an active expiratory phase, which will then allow the ventilator to have full control of the patient’s breathing. This mode mimics our natural physiology and facilitates the use of our pulmonary musculature during inspiration and expiration to manage carbon dioxide retention without the cardiovascular repercussions associated with positive pressure ventilation.

Lung Recruitment

BCV has been proven to assist in the opening of the lung using it's negative extrathoracic pressure. This allows the lungs to fill more thoroughly with air, and in patients with partially congested airways, such as those with RSV Bronchiolitis, this can allow for greater gas exchange.

Secretion Clearance

BCV incorporates a secretion clearance functionality to break up the thick secretions, and cough assist to mobilize those secretions to the upper airways to be coughed out. Used as a scheduled therapy throughout the day, it is an effective too to assist with keeping the lungs clear of secretions.

How Does BCV Impact These Patients?

Biphasic Cuirass Ventilation (BCV) is a non-invasive, effective method of respiratory support for adults and infants alike. It can allow younger patients to move, talk, breathe, and eat more freely, while not requiring traumatic interventions such as an intubation. BCV's non-invasive cuirass can minimize the unnecessary side effects of prolonged use of positive pressure ventilation and decrease hospital readmissions, time spent in the ICU, and in the hospital.

Increased Lung Recruitment

  • BCV works in conjunction with your bodies physiology to naturally fill more of the lung with air

Better Patient Experience

  • By allowing patients to continue to eat and drink, as well as speak to their loved ones, BCV fosters patient independence, and active involvement with their treatment.

Increased Cardiac Output

  • A brief period of cuirass NPV increases cardiac output of patients.

Want to Learn More?

Sign up today to learn more about how Hayek is supporting our patients: